ArticleRespiratory research2024

The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.

Ioannis Grigoropoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.